SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 25 Jul 2024
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
91320-1799
Serial Number
86523783 filed on 04th Feb 2015
Registration Number
5428730 registered on 20th Mar 2018
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
PARSABIV
Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders
First Use Date in General
03rd Jan 2018
First Use Date in Commerce
03rd Jan 2018
Specimens
Mark Details
Serial Number
No 86523783
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-1464-US-1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Jul 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 25th Jul 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 25th Jul 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th Jan 2024 | TEAS SECTION 8 & 15 RECEIVED |
| 20th Mar 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 07th Mar 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 07th Mar 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 20th Mar 2018 | REGISTERED-PRINCIPAL REGISTER |
| 14th Feb 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 13th Feb 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |